GLOW

$49.99

Dosage

70 MG (BPC 157 10mg + TB500 10mg + GHK-CU 50mg)

Clear

GLOW is a research peptide studied for its potential role in appetite regulation and weight-focused metabolic research through central satiety signaling pathways.

For research use only • Not for human consumption

Strictly for Research Application

This compound is supplied exclusively for in vitro laboratory experimentation. It is strictly prohibited for use in diagnostics, therapeutics, or clinical procedures involving humans or animals. This product is not suitable for dietary, cosmetic, or veterinary purposes and has not been evaluated by the FDA or any medical regulatory authority.

Disclaimer: All content provided is for educational reference only. We make no claims regarding the safety or efficacy of this material. The buyer accepts full responsibility for compliance with all federal and local regulations governing the use of research materials.

Terms of Purchase

By completing a purchase from Alpha Peptides & ALPHAPEP LLC, you acknowledge that you are a qualified researcher possessing the necessary expertise to handle and store these materials safely. All sales are final. The supplier assumes no liability for any misuse, negligence, or unintended consequences resulting from this product.

Description
Additional information

What is GLOW?

GLOW is an investigational peptide studied for its potential role in appetite regulation, weight management, and metabolic optimization. It is being explored in preclinical models focused on caloric intake reduction and satiety signaling, particularly within the hypothalamic pathways.

Mechanism of Interest

While specific binding targets are still under investigation, GLOW is believed to influence appetite-related hormones and central nervous system signaling associated with hunger control. It is often researched alongside other peptides targeting obesity and energy balance.

Why Researchers Study GLOW

Explored for reducing food intake and promoting satiety in experimental models
Studied for its potential synergy with GLP-1 and amylin analogs
Considered in obesity, metabolic syndrome, and caloric regulation studies

Note: This product is provided for laboratory research purposes only. It is not intended for human consumption, medical, diagnostic, or therapeutic use.

Weight	0.125 lbs
Dimensions	4 × 2 × 2 in
Dosage	70 MG (BPC 157 10mg + TB500 10mg + GHK-CU 50mg)

GLOW

What is GLOW?

Mechanism of Interest

Why Researchers Study GLOW

Related products

BPC-157 + TB-500

TB-500